A little pill may mean big news for people suffering from multiple sclerosis.
A new study out of the London School of Medicine and Dentistry shows a drug called "cladribine" significantly reduces MS relapse and deterioration, without the unpleasant side effects linked to existing therapies.
Doctors followed more than 1300 MS patients for two years.
Compared to those taking a dummy pill, those who received cladribine tablets were 55 percent less likely to suffer a relapse, and 30 percent less likely to have their disabilities worsen.
Multiple sclerosis is a neurological condition that interferes with the brain's ability to communicate with other parts of the body causing problems with muscle control, vision, hearing and memory.
Researchers say the cladribine works by suppressing the immune system enough for it not to attack the nervous system.
The study appears in The New England Journal of Medicine.
source: wctv.tv
No comments:
Post a Comment